*Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

27

Transcript of *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

Page 1: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.
Page 2: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

**AuthorsAuthors

1-Shaymaa I. Salem,

2-Sherein S.A. Elgayed,

3-W.M. Kelany

1-Abeer A. Abd El-Baky

Page 3: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.
Page 4: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

AimAim

• In our study, we didn’t find any Egyptian paper deal with the cytological findings

associated with acetaminophen toxicity.

• In addition to the present study aimed to determine which of the following tools; ultrasonographic, clinicopathological,

cytological and histopathological examinations, were more rapid and accurate for the diagnosis of acetaminophen toxicity in its maximum therapeutic and toxic dose.

Page 5: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.
Page 6: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

17 Mongrel dogs

5 dogs left without receiving any treatment as a control group

6 dogs received 128 mg kg-1 B.W as a maximum therapeutic dose of acetaminophen

6 dogs received 200 mg kg-1 B.W as a toxic dose of acetaminophen

Page 7: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

Experimental designExperimental design

•The experiment continued for 10 The experiment continued for 10 days, through which clinical days, through which clinical

signs, clinical examination and signs, clinical examination and collection of samples from all collection of samples from all

groups were performed at the 3groups were performed at the 3rdrd and 10and 10thth days post treatment days post treatment

Page 8: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

MethodsMethods

• All groups were subjected to:All groups were subjected to:

1-Ultrasonographic examinations.

2-Clinicopathological examinations.2-Clinicopathological examinations.

3-Cytological examinations.3-Cytological examinations.

4-Histopathological examinations. 4-Histopathological examinations.

Page 9: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.
Page 10: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

Clinical signsClinical signs

1-Anorexia. 2-Weight loss.1-Anorexia. 2-Weight loss.

3-Weakness. 4-Tachypnea.3-Weakness. 4-Tachypnea.

5-Dyspnea. 6-Icterus.5-Dyspnea. 6-Icterus.

7-Hypothermia. 8-Lethargy and apathy.7-Hypothermia. 8-Lethargy and apathy.

(appeared at 3(appeared at 3rdrd day and more prounonced on day and more prounonced on 1010thth day in both 2 day in both 2ndnd and 3 and 3rdrd group) due to group) due to

hemolytic anemia. hemolytic anemia.

Page 11: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

Clinical examinationClinical examination

1-Significant increases in pulse and respiratory 1-Significant increases in pulse and respiratory rates.rates.

2-Rectal temperature (normal to subnormal).2-Rectal temperature (normal to subnormal).

3-Anterior abdominal pain with moderate liver 3-Anterior abdominal pain with moderate liver enlargementenlargement

1 and 2 1 and 2 (appeared at 3(appeared at 3rdrd day and more day and more prounonced on 10prounonced on 10thth day in both 2 day in both 2ndnd and 3 and 3rdrd

group) due to hemolytic anemia. group) due to hemolytic anemia.

Page 12: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

• Fig. (1)Scan-A: Normal sagittal scan of the liver (L) parenchyma appeared homogenous

moderately hypoechoic interrupted by echolucent gall bladder and margined by

hyperechoic diaphragm (D).

Ultrasonographic Findings

Page 13: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

• Scan-B: Double B-scan displaying that echogenicity of the spleen was nearly isoechoic with or more echoic

than liver parenchyma. Liver parenchyma was little bit more echoic than renal cortex of left kidney (L.K.) with prominence of echogenic portal vein walls at the same

depth and gain settings (control dog).

Page 14: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

• Scan-C: Hepatic scan of second group at the 3rd day (p.t) revealed moderate echoic liver parenchyma interrupted

with anechoic gall bladder.

Page 15: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

• Scan-D: Hepatic scan of third group at the 3rd day (p.t) showed moderate increase in echogenicity and less

clearance of echogenic portal vein walls.

Page 16: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

•Scan-E: Hepatic scan of second group at the 10th day (p.t) displayed

marked diffuse hyper-echodensity and less clearance of echogenic

portal vein wall.

Page 17: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

• Scan-F: Sagittal double B-scan of liver, spleen and kidney of third group at the 10th day (p.t) revealed

markedly diffuse hyper-echogenicity of hepatic parenchyma and disappearance of echogenic portal

vein wall. Hepatic parenchyma showed marked increases in the echodensity than the spleen and renal cortex. Renal cortex displayed increased echodensity

than spleen.

Page 18: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

Clinicopathological findingsClinicopathological findings

1-Hemolytic anemia (HB, MCHC).Eccentrocyte, Hienz body.Stress leucocytosis then leucopenia.

2-Increases activities of liver enzymes as well as serum bilirubin, blood glucose, blood urea nitrogen (BUN) and serum creatinine concentrations

in all experimental dogs were observed

(appeared at 3(appeared at 3rdrd day and more prounonced on 10 day and more prounonced on 10thth day in both 2day in both 2ndnd and 3 and 3rdrd group which more group which more aggressive in 3aggressive in 3rdrd group) group).

Page 19: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.
Page 20: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.
Page 21: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.
Page 22: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.
Page 23: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.
Page 24: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.
Page 25: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.
Page 26: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.

1- the present study recommended that, acetaminophen should be used only in limited

amounts for limited periods as its signs of toxicity appeared even with its therapeutic dose.

2-Ultrasonographic examination was a sensitive tool in defining the nature of lesions in most cases of mild acetaminophen toxicity. On the

other hand, cytological findings should be correlated with hematological and serum

biochemical examinations to avoid unrealistic expectations and over interpretation.

Page 27: *Authors 1-Shaymaa I. Salem, 2-Sherein S.A. Elgayed, 3-W.M. Kelany 1-Abeer A. Abd El-Baky.